LIFETECH SCIENTIFIC CORPORATION's next confirmed earnings release is scheduled for March 31, 2027.
| Earnings Date | 3/31/2027 |
As of June 30, 2026, LIFETECH SCIENTIFIC CORPORATION has 4.40B shares outstanding.
| Shares Outstanding | 4.40B |
As of June 30, 2026, LIFETECH SCIENTIFIC CORPORATION maintains a current ratio of 2.45, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.45 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.43 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 1,240.00 |
As of the close on October 26, 2026, LIFETECH SCIENTIFIC CORPORATION's stock has declined approximately 14.35% over the past 52 weeks.
| 52-Week Price Change | -14.35% |
As of June 30, 2026, LIFETECH SCIENTIFIC CORPORATION holds 182.19M in cash and equivalents against 2.08M in total debt, resulting in a net debt position of -139.84M. Total book value stands at 489.25M, with working capital of 180.62M providing operational flexibility.
| Cash & Cash Equivalents | 182.19M |
| Total Debt | 2.08M |
| Net Debt | -139.84M |
| Equity (Book Value) | 489.25M |
| Book Value Per Share | 0.11 |
| Working Capital | 180.62M |
LIFETECH SCIENTIFIC CORPORATION's most recent stock split took place on January 12, 2015 with a 1:8 split ratio.
| Last Split Date | 1/12/2015 |
| Split Ratio | 1:8 |
Already premium?